Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 1831 AL 1845

Small molecules targeting γ-secretase and their potential biological applications

Wen J, Liu D, Zhao L.

Eur J Med Chem. 2022 Mar 15;232:114169. doi: 10.1016/j.ejmech.2022.114169. Epub 2022 Feb 1.

Costs associated with treatment of insomnia in Alzheimer's disease caregivers: a comparison of mindfulness meditation and cognitive behavioral therapy for insomnia

Bentley TGK, Castillo D, Sadeghi N, Piber D, Carroll J, Olmstead R, Irwin MR.

BMC Health Serv Res. 2022 Feb 19;22(1):231. doi: 10.1186/s12913-022-07619-w.

Effects of Resveratrol Supplementation on the Cognitive Function of Patients with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials

Tosatti JAG, Fontes AFDS, Caramelli P, Gomes KB.

Drugs Aging. 2022 Apr;39(4):285-295. doi: 10.1007/s40266-022-00923-4. Epub 2022 Feb 21.

Promising heterocycle-based scaffolds in recent (2019-2021) anti-Alzheimer's drug design and discovery

Dorababu A.

Eur J Pharmacol. 2022 Apr 5;920:174847. doi: 10.1016/j.ejphar.2022.174847. Epub 2022 Feb 23.

Therapeutic strategies for tauopathies and drug repurposing as a potential approach

Islam M, Shen F, Regmi D, Du D.

Biochem Pharmacol. 2022 Apr;198:114979. doi: 10.1016/j.bcp.2022.114979. Epub 2022 Feb 24.

How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer's disease treatment?

Séguy L, Groo AC, Malzert-Fréon A.

Drug Discov Today. 2022 Jun;27(6):1575-1589. doi: 10.1016/j.drudis.2022.02.022. Epub 2022 Feb 25.

Disease-Modifying Therapies for Alzheimer's Disease: More Questions than Answers

Golde TE.

Neurotherapeutics. 2022 Jan;19(1):209-227. doi: 10.1007/s13311-022-01201-2. Epub 2022 Feb 28.

Acupuncture-related treatments improve cognitive and physical functions in Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials

Lin CJ, Yeh ML, Wu SF, Chung YC, Lee JC.

Clin Rehabil. 2022 May;36(5):609-635. doi: 10.1177/02692155221079117. Epub 2022 Mar 1.

Stem cell therapy for Alzheimer's disease: An overview of experimental models and reality

Qin C, Wang K, Zhang L, Bai L.

Animal Model Exp Med. 2022 Feb;5(1):15-26. doi: 10.1002/ame2.12207. Epub 2022 Jan 29.

Mechanisms of Acupuncture in Improving Alzheimer's Disease Caused by Mitochondrial Damage

Jiang YH, He JK, Li R, Chen ZH, Jia BH.

Chin J Integr Med. 2022 Mar;28(3):272-280. doi: 10.1007/s11655-022-3511-6. Epub 2022 Mar 1.

"Aducanumab" making a comeback in Alzheimer's disease: An old wine in a new bottle

Behl T, Kaur I, Sehgal A, Singh S, Sharma N, Makeen HA, Albratty M, Alhazmi HA, Felemban SG, Alsubayiel AM, Bhatia S, Bungau S.

Biomed Pharmacother. 2022 Apr;148:112746. doi: 10.1016/j.biopha.2022.112746. Epub 2022 Feb 26.

Challenges and Approaches of Drugs Such as Memantine, Donepezil, Rivastigmine, and Aducanumab in the Treatment, Control and Management of Alzheimer's Disease

Saeedi M, Mehranfar F.

Recent Pat Biotechnol. 2022;16(2):102-121. doi: 10.2174/1872208316666220302115901.

Medication reconciliation role and value in Alzheimer's disease treatment

Shen X, Zhang Q, Shao W, Shi J, Liu B.

Arq Neuropsiquiatr. 2022 Mar;80(3):233-239. doi: 10.1590/0004-282X-ANP-2021-0147.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias